Serum superoxide dismutase (SOD), malondialdehyde (MDA) ,IL-6, IL-8, TNF-α, serum immune markers after Allogeneic Blood Transfusion in Patients with Gastrointestinal Bleeding

serum SOD and MDA , IL-6, IL-8, TNF-α,

  • Zaikai Lin Zaikai Lin 2Department of General Surgery, Jing'An District Centre Hospital of Shanghai (Huashan Hospital Fudan University Jing'An Branch), Shanghai, 200040, China.
DOI: https://doi.org/10.5937/jomb0-56287
Keywords: serum superoxide dismutase (SOD) , malondialdehyde (MDA) IL-6, IL-8,TNF-α, allogeneic blood transfusion; gastrointestinal bleeding; inflammatory factors; platelets function; immune globulin; ,

Abstract


Aim:this article was to analyze the changes serum superoxide dismutase (SOD), malondialdehyde (MDA) ,IL-6, IL-8, TNF-α, serum immune markers indicators in the serum of patients with gastrointestinal hemorrhage and the impact on the immune function of the body after allogeneic blood transfusion (ABT) during surgery.

Methods:80 patients who diagnosed with gastrointestinal bleeding (GIB) and required surgical treatment were enrolled. 40 patients in the experimental group (EG) were given intravenous infusion of 2 ~ 4 U of red blood cells during the surgery, and 40 patients in the control group (CG) were not treated with allogeneic blood transfusion during the surgery. The cubital venous blood of patients was drawn before the ABT and 1 day after the ABT to check the changes in the T cell subsets, natural killer cells (NKC), immune globulin, serum inflammatory factors, count of platelets, oxidative stress indicators, and hemostasis time.

Results: 1 day after ABT, NKC, CD3+, CD4+, and CD4+/CD8+ in the EG were much lower as against prior to ABT; the immunoglobulin G (IgG) in the EG was lower (P< 0.05); the changes of IgA, and IgM in patients were not obvious (P> 0.05); and IL-6, IL-8, and tumor necrosis factor α (TNF)-α were greatly increased (P< 0.05). The counts of platelet the two groups were reduced prior to ABT and one day after ABT, but the changes were not obvious (P> 0.05). After ABT, the increase in serum superoxide dismutase (SOD) and the decrease in malondialdehyde (MDA) in the EG were greater as against the CG; The hemostasis time (the disappearance of coffee-like substances or the disappearance of blood in the excrement) and the time for occult blood to become negative in the EG were shorter as against the CG (all P< 0.05).

Conclusion: It suggested that the ABT was effective in the treatment of GIB, but it had a visible inhibitory effect on immune function. In addition, the amount of ABT had no visible effect on the platelet function of patients within a certain range, and the oxidative stress indicators of patients changed obviously after ABT, indicating that it can inhibit the peroxide response of patients with GIB.

References

Alzoubaidi, D., Hussein, M., Rusu, R., Napier, D., Dixon, S., Rey, J.W., Steinheber, C., Jameie-Oskooei, S., Dahan, M., Hayee, B., Gulati, S., Despott, E., Murino, A., Subramaniam, S., Moreea, S., Boger, P., Hu, M., Duarte, P., Dunn, J., Mainie, I., McGoran, J., Graham, D., Anderson, J., Bhandari, P., Goetz, M., Kiesslich, R., Coron, E., Lovat, L. and Haidry, R., 2020. Outcomes from an international multicenter registry of patients with acute gastrointestinal bleeding undergoing endoscopic treatment with Hemospray. Dig. Endosc., 32(1): 96-105. https://doi.org/10.1111/den.13502
Barinov, A., Galgano, A., Krenn, G., Tanchot, C., Vasseur, F. and Rocha, B., 2017. CD4/CD8/Dendritic cell complexes in the spleen: CD8+ T cells can directly bind CD4+ T cells and modulate their response. PLoS One, 12(7): e0180644. https://doi.org/10.1371/journal. pone.0180644
Barkun, A.N., Almadi, M., Kuipers, E.J., Laine, L., Sung, J., Tse, F., Leontiadis, G.I., Abraham, N.S., Calvet, X., Chan, F.K.L., Douketis, J., Enns, R., Gralnek, L.M., Jairath, V., Jensen, D., Lau, J., Lip, G.Y.H., Loffroy, R., Maluf-Filho, F., Meltzer, A.C., Reddy, N., Saltzman, J.R., Marshall, J.K. and Bardou, M., 2019. Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the international consensus group. Ann. Intern. Med., 171(11): 805-822. https://doi.org/10.7326/M19-1795
Bian, Z., Liu, J., Xu, L.P., Chang, Y.J., Zhang, X.H. and Huang, X.J., 2017. Association of epstein-barr virus reactivation with the recovery of CD4/CD8 double-negative T lymphocytes after haploidentical hematopoietic stem cell transplantation. Bone Marrow Transplant., 52(2): 264-269. https://doi.org/10.1038/bmt.2016.238
Boateng, L.A., Ngoma, A.M., Bates, I. and Schonewille, H., 2019. Red blood cell alloimmunization in transfused patients with sickle cell disease in sub-saharan africa; a systematic review and meta-analysis. Transfus. Med. Rev., 33(3): 162-169. https://doi.org/10.1016/j. tmrv.2019.06.003
Bond, A. and Smith, P.J., 2019. British society of gastroenterology: diagnosis and management of acute lower gastrointestinal bleeding. Frontline Gastroenterol., 10(4): 417-420. https://doi.org/10.1136/flgastro-2019-101220
Carlsten, M. and Järås, M., 2019. Natural killer cells in myeloid malignancies: immune surveillance, NK cell dysfunction, and pharmacological opportunities to bolster the endogenous NK cells. Front. Immunol., 10: 2357. https://doi.org/10.3389/fimmu.2019.02357
Carson, J.L., Stanworth, S.J., Roubinian, N., Fergusson, D.A., Triulzi, D., Doree, C. and Hebert, P.C., 2016. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst. Rev., 10(10): CD002042. https://doi.org/10.1002/14651858.CD002042.pub4
Caviglia, G.P., Rosso, C., Stalla, F., Rizzo, M., Massano, A., Abate, M.L., Olivero, A., Armandi, A., Vanni, E., Younes, R., Fagoonee, S., Pellicano, R., Astegiano, M., Saracco, G.M., Bugianesi, E. and Ribaldone, D.G., 2020. On-treatment decrease of serum interleukin-6 as a predictor of clinical response to biologic therapy in patients with inflammatory bowel diseases. J. Clin. Med., 9(3): 800. https://doi.org/10.3390/jcm9030800
Desborough, M.J., Oakland, K.A., Landoni, G., Crivellari, M., Doree, C., Estcourt, L.J. and Stanworth, S.J., 2017. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials. J. Thromb. Haemost., 15(2):263-272. https://doi.org/10.1111/jth.13576
Gruber, D.R., Richards, A.L., Howie, H.L., Hay, A.M., Lebedev, J.N., Wang, X.D., Zimring, J.C. and Hudson, K.N., 2020. Passively transferred IgG enhances humoral immunity to a red blood cell alloantigen in mice. Blood Adv., 4(7): 1526-1537. https://doi.org/10.1182/bloodadvances.2019001299
Gupta, K., Khan, A., Kumar, M., Sawalha, K., Abozenah, M. and Singhania, R., 2021. Readmissions rates after myocardial infarction for gastrointestinal bleeding: a national perspective. Dig. Dis, Sci., 66(3): 751-759. https://doi.org/10.1007/s10620-020-06315-1
HALT-IT Trial Collaborators, 2020. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet, 395(10241): 1927-1936. https://doi.org/10.1016/S0140-6736(20)30848-5
Holster, I.L., Hunfeld, N.G., Kuipers, E.J., Kruip M.J.H.A. and Tjwa. E.T.T.L., 2013. On the treatment of new oral anticoagulant-associated gastrointestinal hemorrhage. J. Gastrointestin. Liver Dis., 22(2): 229-231. https://doi.org/10.5754/hge12881
Kably, I.M., Ziga, E.D. and Andreansky, M., 2015. Intra-arterial platelet infusion for intractable hemorrhage and refractory thrombocytopenia in children with gastrointestinal graft-versus-host disease. Pediatr. Blood Cancer, 62(12): 2226-2228. https://doi.org/10.1002/pbc.25633
Lee, S.R., Kwon, S., Choi, E.K., Jung, J.H., Han, K.D., Oh, S. and Lip G.Y.H., 2021. Proton pump inhibitor co-therapy in patients with atrial fibrillation treated with oral anticoagulants and a prior history of upper gastrointestinal tract bleeding. Cardiovasc. Drugs Ther., https://doi.org/10.1007/s10557-021-07170-6
Li J, Lei J, He L, Fan, X., Yi, F.M. and Zhang, W.X., 2019. Evaluation and monitoring of superoxide dismutase (SOD) activity and its clinical significance in gastric cancer: a systematic review and meta-analysis. Med. Sci. Monit., 25: 2032-2042. https://doi.org/10.12659/MSM.913375
Mannami, T., Fujiwara, N., Ikeda, G., Mishima, T., Kuroi, T., Muraoka, T. and Othawa, Y., 2019. Gastrointestinal hemorrhage caused by the direct invasion of a hepatocellular carcinoma successfully treated with polyglycolic acid sheet shielding. Endoscopy, 51(2): E20-E21. https://doi.org/10.1055/a-0747-5467
Miura, Y., Iwamoto, F., Ishida, Y., Kuno, T., Tanaka, K., Kobayashi, S., Yoshida, T., Yamaguchi, T., Sato, T. and Enomoto, N., 2019. [Refractory eosinophilic gastroenteritis with gastritis, duodenal ulcer, and colitis: a case report]. Nihon Shokakibyo Gakkai Zasshi, 116(8): 668-675. https://doi.org/10.11405/nisshoshi.116.668
Mullady, D.K., Wang, A.Y. and Waschke, K.A., 2020. AGA clinical practice update on endoscopic therapies for non-variceal upper gastrointestinal bleeding: expert review. Gastroenterology, 159(3): 1120-1128. https://doi.org/10.1053/j. gastro.2020.05.095
Nakanishi, K., Kanda, M. and Kodera, Y., 2019. Long-lasting discussion: adverse effects of intraoperative blood loss and allogeneic transfusion on prognosis of patients with gastric cancer. World J. Gastroenterol., 25(22): 2743-2751. https://doi.org/10.3748/wjg.v25.I22.2743
Oakland, K., Chadwick, G., East, J.E., Richard, G., Humphries, A., Jairath, V., McPherson, S., Metzner, M., Morris, A.J., Murphy, M.F., Tham, T., Uberoi, R., Veitch, A.M., Wheeler, J. Regan, C. and Hoare, J., 2019. Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the british society of gastroenterology. Gut, 68(5): 776-789. https://doi.org/10.1136/gutjnl-2018-317807
Otani, K., Watanabe, T., Shimada, S., Hosomi, S., Nagami, Y., Tanaka, F., Kamata, N., Taira, K ., Yamagami, H. and Tanigawa, T., 2018. Clinical utility of capsule endoscopy and double-balloon enteroscopy in the management of obscure gastrointestinal bleeding. Digestion, 97(1): 52-58. https://doi.org/10.1159/000484218
Patel, S.D., Desai, R., Patel, U., Singh, S., Patel, Z., Patel, N., Zhang, A., Panwala, A.H., Khan, V.N., Singh, G. and Shah, N., 2019. Thirty-day readmissions after upper and lower gastrointestinal hemorrhage: a national perspective in the united states. J. Clin. Gastroenterol., 53(8): 582-590. https://doi.org/10.1097/MCG.0000000000001020
Polak, D., Talar, M., Watala, C. and Przygodzki, T., 2020. Intravital assessment of blood platelet function. a review of the methodological approaches with examples of studies of selected aspects of blood platelet function. Int. J. Mol. Sci., 21(21): 8334. https://doi.org/10.3390/ijms21218334.
Ray, W.A., Chung, C.P., Murray, K.T., Smalley, W.E., Daugherty, J.R., Dupont, W.D., Stein, C.M., 2018. Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding. JAMA, 320(21): 2221-2230. https://doi.org/10.1001/jama.2018.17242
Satoh-Takayama, N., Kato, T., Motomura, Y., Kageyama, T., Taguchi-Atarashi, N., Kinoshita-Daitoku R, Kuroda E, Di Santo, J.P., Mimuro, H., Moro, K. and Ohno, H., 2020. Bacteria-induced group 2 innate lymphoid cells in the stomach provide immune protection through induction of IgA. Immunity, 52(4): 635-649.e4. https://doi.org/10.1016/j. immuni.2020.03.002
Tsikas, D., 2017. Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges. Anal. Biochem., 524: 13-30. https://doi.org/10.1016/j.ab.2016.10.021
Zhang, J., Chi, H., Xiao, H., Tian, X., Wang, Y., Yun, X. and Xu, Y.C., 2017. Interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) single nucleotide polymorphisms (SNPs), inflammation and metabolism in gestational diabetes mellitus in inner mongolia. Med. Sci. Monit., 23: 4149-4157. https://doi.org/10.12659/msm.903565
Zhou, P.L., Wu, G., Han, X.W., Yan, L. and Zhang, W.G., 2017. Budd-chiari syndrome with upper gastrointestinal hemorrhage: characteristic and long-term outcomes of endovascular treatment. Vascular, 25(6): 642-648. https://doi.org/10.1177/1708538117710087
Published
2025/04/03
Issue
Ahead of print
Section
Original paper

Copyright (c) 2025 Zaikai Lin Zaikai Lin

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.